11 Updated Stocks and the Sad Story They Tell [View article]
A really sad story about the pharmas is if Congress attempts to strong arm them into discounting drugs with no incentive to acquire a massive amount of new patients in exchange. I am in Consumer Healthcare marketing. The clinical trial business flocked overseas this last year in a microsecond. If Obama is going to keep talking about negotiations with the drug companies he should be publically highlighting a mutual value proposition to begin breaking ranks from the Henry Waxman's of the world.
11 Updated Stocks and the Sad Story They Tell [View article]